Skip to main content

MoneyWorks4Me

Granules India informs about press release

05 Mar 2026 Evaluate
Granules India has enclosed a copy of Press Release titled ‘Granules India’s Packaging Facility in US gets FDA EIR with No Action Indicated Status’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..